Screener
Candel Therapeutics, Inc. CADL Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-222904
| Line item | MARCH 31,2026(Unaudited) | DECEMBER 31,2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $194,834 | $119,731 |
| Prepaid expenses and other current assets | 2,918 | 1,658 |
| Total current assets | 197,752 | 121,389 |
| Fixed assets, net | 2,075 | 1,642 |
| Lease right of use assets | 1,569 | 1,661 |
| Restricted cash | 416 | 416 |
| Other assets | 108 | 87 |
Item 1. Financial Statements.
FAQ
- What is Candel Therapeutics, Inc.'s total current assets?
- Candel Therapeutics, Inc. (CADL) reported total current assets of $197.75M in Q1 2026.
- How has Candel Therapeutics, Inc.'s total current assets changed year-over-year?
- Candel Therapeutics, Inc.'s total current assets increased by 112.3% year-over-year, from $93.15M to $197.75M.
- What is the long-term trend for Candel Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Candel Therapeutics, Inc.'s total current assets has grown at a 28.1% compound annual growth rate (CAGR), from $35.15M to $121.39M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Candel Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude